Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Horm Res Paediatr ; 85(1): 69-73, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26457578

RESUMO

BACKGROUND: Prolonged cis-retinoic acid (RA) exposure contributes to premature epiphyseal closure. cis-RA is administered in various treatment regimens for pediatric cancers, thus increasing the risk for bone deformities and compromised growth. RESULTS: We present a case of premature epiphyseal closure in a 9-year-old female with a history of medulloblastoma and treatment with a multimodal regimen including cis-RA. She was subsequently diagnosed with radiation-induced endocrine late effects including hypothyroidism and growth hormone deficiency (GHD). Seven months after initiation of GH therapy, an increased prominence of the wrists and knees combined with a deceleration in growth velocity prompted further evaluation; radiographs revealed bilateral premature closure of the distal femur and proximal tibia growth plates despite normal left wrist bone age. CONCLUSION: High doses of vitamin A and its analogs are linked to premature closure of the lower-extremity growth plates in animals and children. Pediatric brain tumor patients are at increased risk of growth failure due to concurrent radiation-induced GHD, damage to the spinal bones, and cis-RA-associated premature closure of the lower-extremity growth plates, with significant reduction in adult stature. A better appreciation of the detrimental effect of cis-RA on the growing skeleton is needed to monitor at-risk patients and to provide timely interventions.


Assuntos
Doenças Ósseas , Transtornos do Crescimento , Lâmina de Crescimento/patologia , Extremidade Inferior , Meduloblastoma/tratamento farmacológico , Tretinoína/efeitos adversos , Adulto , Doenças Ósseas/induzido quimicamente , Doenças Ósseas/patologia , Criança , Feminino , Transtornos do Crescimento/induzido quimicamente , Transtornos do Crescimento/patologia , Hormônio do Crescimento Humano/deficiência , Humanos , Meduloblastoma/patologia , Tretinoína/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa